Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
15.3M
-
Shares change
-
+253K
-
Total reported value, excl. options
-
$124M
-
Value change
-
+$3.41M
-
Put/Call ratio
-
0.13
-
Number of buys
-
38
-
Number of sells
-
-39
-
Price
-
$8.08
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q3 2018
102 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q3 2018.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 86.6M outstanding shares and own 17.72% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.34M shares), MPM ASSET MANAGEMENT LLC (2.17M shares), BlackRock Inc. (1.76M shares), BVF INC/IL (1.23M shares), DIMENSIONAL FUND ADVISORS LP (796K shares), Vanguard Group Inc (737K shares), MILLENNIUM MANAGEMENT LLC (608K shares), 683 Capital Management, LLC (521K shares), ORBIMED ADVISORS LLC (437K shares), and FMR LLC (349K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.